Lux Health Tech Acquisition Statistics
Share Statistics
Lux Health Tech Acquisition has -
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 7.63 and the forward
PE ratio is null.
Lux Health Tech Acquisition's PEG ratio is
0.
| PE Ratio | 7.63 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | -15.38 |
| P/FCF Ratio | -599847.52 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Lux Health Tech Acquisition has an Enterprise Value (EV) of 422.21M.
| EV / Sales | 0 |
| EV / EBITDA | 15.58 |
| EV / EBIT | -599254.49 |
| EV / FCF | -599254.49 |
Financial Position
The company has a current ratio of 0.71,
with a Debt / Equity ratio of 0.
| Current Ratio | 0.71 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0.04 |
Financial Efficiency
Return on Equity is -201.47% and Return on Invested Capital is 8.79%.
| Return on Equity | -201.47% |
| Return on Assets | 16.02% |
| Return on Invested Capital | 8.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -28.28M |
| Effective Tax Rate | -104.36% |
Stock Price Statistics
The stock price has increased by -0.04% in the
last 52 weeks. The beta is 0, so Lux Health Tech Acquisition's
price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -0.04% |
| 50-Day Moving Average | 10.01 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 49.39 |
| Average Volume (20 Days) | 4,449 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.18M |
| Net Income | 55.38M |
| EBITDA | 27.1M |
| EBIT | n/a |
| Earnings Per Share (EPS) | 1.28 |
Full Income StatementBalance Sheet
The company has 417.82K in cash and 0 in
debt, giving a net cash position of 417.82K.
| Cash & Cash Equivalents | 417.82K |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -27.49M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -704.55
and capital expenditures 0, giving a free cash flow of -704.55.
| Operating Cash Flow | -704.55 |
| Capital Expenditures | n/a |
| Free Cash Flow | -704.55 |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
